Orthofix Medical (OFIX) Competitors

Orthofix Medical logo
$9.31 -0.05 (-0.53%)
Closing price 06/25/2026 04:00 PM Eastern
Extended Trading
$9.31 0.00 (-0.01%)
As of 05:27 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

OFIX vs. MMSI, ATRC, IART, ATEC, and ANGO

Should you buy Orthofix Medical stock or one of its competitors? MarketBeat compares Orthofix Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Orthofix Medical include Merit Medical Systems (MMSI), AtriCure (ATRC), Integra LifeSciences (IART), Alphatec (ATEC), and AngioDynamics (ANGO). These companies are all part of the "medical" sector.

How does Orthofix Medical compare to Merit Medical Systems?

Merit Medical Systems (NASDAQ:MMSI) and Orthofix Medical (NASDAQ:OFIX) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, media sentiment, profitability, institutional ownership, valuation, earnings, analyst recommendations and dividends.

Merit Medical Systems presently has a consensus price target of $92.80, indicating a potential upside of 31.02%. Orthofix Medical has a consensus price target of $15.50, indicating a potential upside of 66.49%. Given Orthofix Medical's higher probable upside, analysts plainly believe Orthofix Medical is more favorable than Merit Medical Systems.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Merit Medical Systems
1 Sell rating(s)
2 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.64
Orthofix Medical
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40

99.7% of Merit Medical Systems shares are owned by institutional investors. Comparatively, 89.8% of Orthofix Medical shares are owned by institutional investors. 0.7% of Merit Medical Systems shares are owned by insiders. Comparatively, 2.7% of Orthofix Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Merit Medical Systems has higher revenue and earnings than Orthofix Medical. Orthofix Medical is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Merit Medical Systems$1.54B2.74$128.49M$2.3130.66
Orthofix Medical$822.31M0.46-$92.19M-$1.51N/A

Merit Medical Systems has a beta of 0.54, meaning that its stock price is 46% less volatile than the broader market. Comparatively, Orthofix Medical has a beta of 0.71, meaning that its stock price is 29% less volatile than the broader market.

In the previous week, Orthofix Medical had 1 more articles in the media than Merit Medical Systems. MarketBeat recorded 4 mentions for Orthofix Medical and 3 mentions for Merit Medical Systems. Merit Medical Systems' average media sentiment score of 1.22 beat Orthofix Medical's score of 0.86 indicating that Merit Medical Systems is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Merit Medical Systems
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Orthofix Medical
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Merit Medical Systems has a net margin of 9.03% compared to Orthofix Medical's net margin of -7.27%. Merit Medical Systems' return on equity of 13.54% beat Orthofix Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Merit Medical Systems9.03% 13.54% 7.94%
Orthofix Medical -7.27%-13.44%-7.05%

Summary

Merit Medical Systems beats Orthofix Medical on 12 of the 16 factors compared between the two stocks.

How does Orthofix Medical compare to AtriCure?

Orthofix Medical (NASDAQ:OFIX) and AtriCure (NASDAQ:ATRC) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, media sentiment, valuation, risk, dividends, analyst recommendations, institutional ownership and earnings.

Orthofix Medical has a beta of 0.71, suggesting that its stock price is 29% less volatile than the broader market. Comparatively, AtriCure has a beta of 1.26, suggesting that its stock price is 26% more volatile than the broader market.

In the previous week, Orthofix Medical had 2 more articles in the media than AtriCure. MarketBeat recorded 4 mentions for Orthofix Medical and 2 mentions for AtriCure. AtriCure's average media sentiment score of 0.96 beat Orthofix Medical's score of 0.86 indicating that AtriCure is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Orthofix Medical
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
AtriCure
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

AtriCure has lower revenue, but higher earnings than Orthofix Medical. AtriCure is trading at a lower price-to-earnings ratio than Orthofix Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Orthofix Medical$822.31M0.46-$92.19M-$1.51N/A
AtriCure$534.53M2.66-$11.45M-$0.10N/A

AtriCure has a net margin of -0.83% compared to Orthofix Medical's net margin of -7.27%. AtriCure's return on equity of 0.29% beat Orthofix Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Orthofix Medical-7.27% -13.44% -7.05%
AtriCure -0.83%0.29%0.22%

Orthofix Medical presently has a consensus target price of $15.50, suggesting a potential upside of 66.49%. AtriCure has a consensus target price of $48.71, suggesting a potential upside of 73.18%. Given AtriCure's stronger consensus rating and higher probable upside, analysts plainly believe AtriCure is more favorable than Orthofix Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Orthofix Medical
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
AtriCure
1 Sell rating(s)
3 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.64

89.8% of Orthofix Medical shares are held by institutional investors. Comparatively, 99.1% of AtriCure shares are held by institutional investors. 2.7% of Orthofix Medical shares are held by company insiders. Comparatively, 4.0% of AtriCure shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

AtriCure beats Orthofix Medical on 14 of the 17 factors compared between the two stocks.

How does Orthofix Medical compare to Integra LifeSciences?

Orthofix Medical (NASDAQ:OFIX) and Integra LifeSciences (NASDAQ:IART) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, institutional ownership, media sentiment, earnings, profitability and dividends.

Orthofix Medical has a beta of 0.71, suggesting that its stock price is 29% less volatile than the broader market. Comparatively, Integra LifeSciences has a beta of 1.24, suggesting that its stock price is 24% more volatile than the broader market.

89.8% of Orthofix Medical shares are held by institutional investors. Comparatively, 84.8% of Integra LifeSciences shares are held by institutional investors. 2.7% of Orthofix Medical shares are held by insiders. Comparatively, 3.8% of Integra LifeSciences shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Orthofix Medical currently has a consensus price target of $15.50, suggesting a potential upside of 66.49%. Integra LifeSciences has a consensus price target of $16.20, suggesting a potential downside of 10.50%. Given Orthofix Medical's stronger consensus rating and higher possible upside, analysts clearly believe Orthofix Medical is more favorable than Integra LifeSciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Orthofix Medical
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
Integra LifeSciences
2 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
1.83

In the previous week, Integra LifeSciences had 1 more articles in the media than Orthofix Medical. MarketBeat recorded 5 mentions for Integra LifeSciences and 4 mentions for Orthofix Medical. Orthofix Medical's average media sentiment score of 0.86 beat Integra LifeSciences' score of 0.66 indicating that Orthofix Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Orthofix Medical
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Integra LifeSciences
0 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Orthofix Medical has higher earnings, but lower revenue than Integra LifeSciences. Orthofix Medical is trading at a lower price-to-earnings ratio than Integra LifeSciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Orthofix Medical$822.31M0.46-$92.19M-$1.51N/A
Integra LifeSciences$1.64B0.86-$516.47M-$6.46N/A

Orthofix Medical has a net margin of -7.27% compared to Integra LifeSciences' net margin of -30.15%. Integra LifeSciences' return on equity of 17.42% beat Orthofix Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Orthofix Medical-7.27% -13.44% -7.05%
Integra LifeSciences -30.15%17.42%5.00%

Summary

Orthofix Medical and Integra LifeSciences tied by winning 8 of the 16 factors compared between the two stocks.

How does Orthofix Medical compare to Alphatec?

Orthofix Medical (NASDAQ:OFIX) and Alphatec (NASDAQ:ATEC) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, profitability, earnings, analyst recommendations, valuation, institutional ownership, media sentiment and risk.

In the previous week, Orthofix Medical had 2 more articles in the media than Alphatec. MarketBeat recorded 4 mentions for Orthofix Medical and 2 mentions for Alphatec. Alphatec's average media sentiment score of 0.93 beat Orthofix Medical's score of 0.86 indicating that Alphatec is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Orthofix Medical
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Alphatec
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

89.8% of Orthofix Medical shares are owned by institutional investors. Comparatively, 66.4% of Alphatec shares are owned by institutional investors. 2.7% of Orthofix Medical shares are owned by company insiders. Comparatively, 13.5% of Alphatec shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Orthofix Medical has a net margin of -7.27% compared to Alphatec's net margin of -15.93%. Orthofix Medical's return on equity of -13.44% beat Alphatec's return on equity.

Company Net Margins Return on Equity Return on Assets
Orthofix Medical-7.27% -13.44% -7.05%
Alphatec -15.93%-1,183.84%-15.83%

Orthofix Medical currently has a consensus target price of $15.50, suggesting a potential upside of 66.49%. Alphatec has a consensus target price of $18.58, suggesting a potential upside of 110.46%. Given Alphatec's stronger consensus rating and higher probable upside, analysts clearly believe Alphatec is more favorable than Orthofix Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Orthofix Medical
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
Alphatec
1 Sell rating(s)
1 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.75

Orthofix Medical has a beta of 0.71, meaning that its share price is 29% less volatile than the broader market. Comparatively, Alphatec has a beta of 0.88, meaning that its share price is 12% less volatile than the broader market.

Orthofix Medical has higher revenue and earnings than Alphatec. Alphatec is trading at a lower price-to-earnings ratio than Orthofix Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Orthofix Medical$822.31M0.46-$92.19M-$1.51N/A
Alphatec$764.16M1.78-$143.36M-$0.82N/A

Summary

Orthofix Medical and Alphatec tied by winning 8 of the 16 factors compared between the two stocks.

How does Orthofix Medical compare to AngioDynamics?

Orthofix Medical (NASDAQ:OFIX) and AngioDynamics (NASDAQ:ANGO) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, institutional ownership, valuation, profitability, media sentiment, earnings and dividends.

Orthofix Medical has a net margin of -7.27% compared to AngioDynamics' net margin of -10.01%. AngioDynamics' return on equity of -4.66% beat Orthofix Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Orthofix Medical-7.27% -13.44% -7.05%
AngioDynamics -10.01%-4.66%-3.08%

Orthofix Medical presently has a consensus target price of $15.50, suggesting a potential upside of 66.49%. AngioDynamics has a consensus target price of $18.67, suggesting a potential upside of 36.65%. Given Orthofix Medical's higher probable upside, equities research analysts plainly believe Orthofix Medical is more favorable than AngioDynamics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Orthofix Medical
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
AngioDynamics
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.67

89.8% of Orthofix Medical shares are owned by institutional investors. Comparatively, 89.4% of AngioDynamics shares are owned by institutional investors. 2.7% of Orthofix Medical shares are owned by company insiders. Comparatively, 6.0% of AngioDynamics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Orthofix Medical has a beta of 0.71, suggesting that its share price is 29% less volatile than the broader market. Comparatively, AngioDynamics has a beta of 0.38, suggesting that its share price is 62% less volatile than the broader market.

In the previous week, Orthofix Medical had 2 more articles in the media than AngioDynamics. MarketBeat recorded 4 mentions for Orthofix Medical and 2 mentions for AngioDynamics. AngioDynamics' average media sentiment score of 1.52 beat Orthofix Medical's score of 0.86 indicating that AngioDynamics is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Orthofix Medical
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
AngioDynamics
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

AngioDynamics has lower revenue, but higher earnings than Orthofix Medical. AngioDynamics is trading at a lower price-to-earnings ratio than Orthofix Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Orthofix Medical$822.31M0.46-$92.19M-$1.51N/A
AngioDynamics$292.50M1.93-$33.99M-$0.75N/A

Summary

AngioDynamics beats Orthofix Medical on 9 of the 16 factors compared between the two stocks.

Get Orthofix Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for OFIX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OFIX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OFIX vs. The Competition

MetricOrthofix MedicalMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$378.35M$7.27B$6.61B$12.27B
Dividend YieldN/A1.27%2.67%5.88%
P/E Ratio-6.1749.6226.0123.97
Price / Sales0.4647.51538.2599.72
Price / CashN/A25.6646.3353.91
Price / Book0.827.4010.686.32
Net Income-$92.19M$159.20M$3.57B$337.22M
7 Day Performance-1.48%0.82%0.80%-1.23%
1 Month Performance-4.71%0.44%0.23%-0.63%
1 Year Performance-15.67%5.87%30.84%27.95%

Orthofix Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OFIX
Orthofix Medical
4.1902 of 5 stars
$9.31
-0.5%
$15.50
+66.5%
-14.4%$378.35M$822.31MN/A1,605
MMSI
Merit Medical Systems
4.3355 of 5 stars
$67.27
+1.2%
$92.80
+38.0%
-23.6%$4.01B$1.54B29.127,500
ATRC
AtriCure
3.5986 of 5 stars
$28.44
flat
$48.71
+71.3%
-12.8%$1.44B$534.53MN/A1,300
IART
Integra LifeSciences
1.5718 of 5 stars
$17.69
+0.5%
$16.20
-8.4%
+52.5%$1.38B$1.64BN/A4,427
ATEC
Alphatec
3.4082 of 5 stars
$8.50
-0.6%
$18.58
+118.6%
-21.4%$1.31B$764.16MN/A700

Related Companies and Tools


This page (NASDAQ:OFIX) was last updated on 6/26/2026 by MarketBeat.com Staff.
From Our Partners